Related Experiment Videos
Therapeutic potential of transfer factor
The New England Journal of Medicine
|August 14, 1980
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.
Clinical and experimental immunology·2014
Chronic mucocutaneous candidiasis.
The Pediatric infectious disease journal·2001
Transfer factors: identification of conserved sequences in transfer factor molecules.
Molecular medicine (Cambridge, Mass.)·2000
Recognition of the immunocompromised patient.
Chest surgery clinics of North America·1999
Profiles of cytokine production in recipients of transfer factors.
Biotherapy (Dordrecht, Netherlands)·1996
Activities and characteristics of transfer factors.
Biotherapy (Dordrecht, Netherlands)·1996
Fibromyalgia.
The New England journal of medicine·2026
Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015.
The New England journal of medicine·2026
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
The New England journal of medicine·2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
The New England journal of medicine·2026
Andes Virus - A Clinical Review.
The New England journal of medicine·2026
Platelet-Activating Anti-Platelet Factor 4 Disorders.
The New England journal of medicine·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026